Raymond Joseph Tesi - 21 Mar 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Raymond Joseph Tesi
Issuer symbol: INMB
Transactions as of: 21 Mar 2022
Net transactions value: +$199,993
Form type: 4
Filing time: 23 Mar 2022, 16:33:16 UTC
Previous filing: 04 Nov 2021
Next filing: 31 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INMB	Common Stock	Award	$199,993	+23,724	+1.6%	$8.43	1,514,398	22 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INMB	Option (right to buy)	Award	$0	+130,000		$0.000000	130,000	21 Mar 2022	Common Stock	130,000	$7.92	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities . These shares were purchased by the Reporting Person directly from Issuer.
F2	Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.